Corentec

What Corentec does

Corentec Co., Ltd. (주식회사 코렌텍) is a South Korean orthopedic implant manufacturer founded in 2000 and listed on the Korea Stock Exchange under ticker 104540. The company designs, manufactures, and markets a comprehensive portfolio of artificial joint implants and sports medicine products across five categories: hip (Bencox/Benfix Hip System with multiple stem and cup variants including Fit Stem, M Stem, ID Stem, Modular Revision Stem, Mirabo Cup, Dual Mobility System, and Bipolar Cup), knee (Exult Knee System, Lospa Knee System, Lospa Modular Knee System), shoulder (Coralis Shoulder System, Humeral Stem-Short), spine (Lospa IS Spinal System), and sports medicine (CorLock Suture Anchor). The company holds 96 domestic and international patents covering implant technologies, including what it describes as the world's first application of 3D printing in artificial joint production, proprietary DMT (Direct Metal Texturing) laser coating with 200-500μm pores for bone in-growth, plasma spray titanium surface treatment, and patented trapezoidal neck geometry for hip stems.

The company's core customer segments are orthopedic surgeons and hospitals performing joint replacement and reconstruction procedures, with secondary exposure to specialty orthopedic clinics requiring customized solutions. Corentec generates revenue primarily through hardware sales of implants via two go-to-market motions: direct sales to Korean hospitals and US surgical centers (through Corentec America, Inc. in Laguna Hills, CA) and international distribution partnerships across Mexico, Saudi Arabia, Brazil, Argentina, Indonesia, Japan, and Ukraine. Pricing is not publicly disclosed but follows typical medical device contract and distributor quoting. The company is ISO 13485 certified, holds FDA, CE, MFDS, ANMAT, KEMKES, and MO3 regulatory approvals, and operates a manufacturing facility in Cheonan-si with sales offices in Seoul and Laguna Hills, CA.

In 2025, Corentec achieved a major business inflection: full-year consolidated revenue of 100.4 billion KRW (approximately $75M USD) grew 17.3% YoY, and operating profit increased 167.2% to 9.018 billion KRW, converting the company to an annual profit. US market entry was catalyzed by FDA approval of the UCR tibial insert for the EXULT Knee System in April 2025, with $6.05M in projected 2025 US revenue and 30%+ annual growth through 2027. The company also signed a $15M three-year distribution MOU with Mexico's Biortotec and participated in multiple global medical exhibitions to expand its international footprint.

Name

Corentec

Legal name

Corentec Co., Ltd.

Website

https://corentec.com

Company type

Public

Founded year

2000

Operating status

Operating

Headcount range

101–250 employees

Short description

Corentec is a South Korean orthopedic implant manufacturer founded in 2000 that designs, produces, and markets hip, knee, shoulder, spine, and sports medicine implants globally, selling to orthopedic surgeons and hospitals through direct sales and distributor networks across nine countries.

Ownership category

akta.pro rank

Headquarters

HQ city

Seoul

HQ country

South Korea

HQ region

Asia

Offices3 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Personnel, Operations, Technology or R&D, Marketing or Sales

Revenue model

1. Orthopedic Implant Sales: Sale of artificial joint implants including hip, knee, shoulder, and spine products. Revenue generated from domestic Korean market and international exports. 2025 performance showed 100.4 billion KRW revenue with 17.3% YoY growth and 167.2% increase in operating profit to 9.018 billion KRW. The company achieved annual profit turnaround in 2025.
2. US Market Revenue (UCR Products): Revenue from FDA-approved UCR knee implant products launched in US market in April 2025. Expected to generate approximately $6.05 million in 2025, with projected growth to $7.86 million in 2026 and over $10 million in 2027 (30%+ annual growth).

Go-to-market motion2 records

Distribution channels3 records

Marketing channels4 records

Core offering

Corentec designs, manufactures, and markets a comprehensive line of orthopedic implants including artificial hip, knee, shoulder, and spine systems, along with sports medicine suture anchors. Founded in 2000 as Korea's first specialized artificial joint manufacturer, the company holds 96 patents and serves hospitals and orthopedic surgeons globally through direct sales and distributor networks.

Product overview

Corentec is a Korean orthopedic medical device company offering a comprehensive portfolio of artificial joint implants and sports medicine products. The product portfolio spans five main categories: HIP (Bencox/Benfix Hip System with multiple stem and cup variants including Fit Stem, M Stem, ID Stem, Modular Revision Stem, Mirabo Cup, Dual Mobility System, and Bipolar Cup), KNEE (Exult Knee System, Lospa Knee System, and Lospa Modular Knee System for primary and revision procedures), SHOULDER (Coralis Shoulder System and Humeral Stem-Short enabling anatomical to reversed prosthesis conversion), SPINE (Lospa IS Spinal System with interbody cages and pedicle screws), and SPORTS MEDICINE (CorLock Suture Anchor line including Selfix and Biocomposite variants). The company is recognized as Korea's first artificial joint specialist manufacturer, established in 2000, with 96 patents in orthopedic implants and global regulatory approvals including FDA, CE, and MFDS.

Differentiator

Problem solved

Functional benefit

Brands

• Bencox: Hip implant system including Bencox Fit Stem, Bencox M Stem, Bencox ID Stem, Bencox Modular Revision Stem, Bencox Mirabo Cup, Bencox Dual Mobility System, and Bencox Bipolar Cup.
• Benfix
• Exult
• Lospa
• Coralis
• CorLock

Products and services

• Bencox Hip System Comprehensive hip replacement product line including multiple stem designs (Bencox Fit Stem, Bencox M Stem, Bencox ID Stem, Bencox Modular Revision Stem, Benfix Long Stem) and cup systems (Bencox Mirabo Cup, Bencox Dual Mobility System, Bencox Bipolar Cup), featuring patented trapezoidal neck geometry for improved range of motion and reduced dislocation risk.
• Exult Knee System Primary knee replacement system featuring lateralized anterior trochlea groove for optimal patella tracking, spherical articular surface for reducing contact stress, and multi-radius sagittal plane design. Now offers four insert options (CR, PS, CPS, UCR) allowing surgeons to perform surgery whether they want to resect or preserve the posterior cruciate ligament.
• Lospa Knee System Single-axis knee system designed for articular stability with flexion and improved range of motion, featuring anterior flange shape for optimal patella tracking and sphere-shaped articular surface for reducing contact stress.
• Lospa Modular Knee System Revision knee system with modular femoral component featuring 6° laterally tilted stem housing, concave curved post for dislocation risk reduction, and augment options for bone deficit complementing.
• Coralis Shoulder System Shoulder replacement system allowing easy conversion from anatomic or hemi to reversed prosthesis without stem removal. Features 145° humeral inclination for improved adduction and reduced scapular notching, with multiple Humeral Tray and Glenosphere options.
• Lospa IS Spinal System Comprehensive spinal fixation solution including interbody fusion cages (ACIF, PLIF, TLIF, T-PLIF, OLIF approaches), posterior and MIS pedicle screws with self-tapping design, and tantalum markers for accurate implant placement visualization.
• CorLock Suture Anchor Sports medicine suture anchor line featuring biocomposite and self-fixation designs, including CorLock Selfix with dual thread for cortical and cancellous bone engagement and CorLock Biocomposite variants for various joint sizes including ankle and elbow applications.

Quantifiable outcome

• 23% increase in lateral dislocation resistance compared to conventional 36mm fixed bearing (Dual Mobility System)
• +3 more outcomes

Segments2 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature7 records

Partnerships

Two partnerships are on record, tiered core and minor.

• BiortoteccoreChannel Partner/ Reseller/ Distributor · 18 November 2025Mexican medical device distributor partnership for distribution of Corentec orthopedic implants. MOU signed at KOTRA Global Connect 2025 for approximately $15 million USD cooperation over 3 years. Biortotec's Chief Operating Director Mr. Orlando visited for partnership discussions.
• Middle East Hospitals and DistributorsminorChannel Partner/ Reseller/ Distributor · 27 October 2025Collaboration discussions with hospitals and distributors in the Middle East region initiated at Global Health Exhibition 2025 in Riyadh, Saudi Arabia for potential distribution partnerships.

Scale indicators7 records

Recent moves8 records

Expansion highlights6 records

Broad incumbents

• Stryker Corporation: Stryker is a global medical device leader with major orthopedic implants (knees, hips, trauma, Mako robotics) business directly competing with Corentec's hip, knee, and trauma portfolio. As a $20B+ revenue incumbent, it dwarfs Corentec but represents the competitive benchmark Corentec must displace in US hospitals.
• Zimmer Biomet: Zimmer Biomet is one of the world's largest orthopedic reconstruction companies (hips, knees, extremities) and a direct competitor to Corentec's joint reconstruction portfolio. Its established US sales force, Persona Knee and G7 hip systems, and Rosa robotics platform represent both competitive threat and partnership opportunity.
• Smith+Nephew: Smith+Nephew is a UK-based global medical device company with a major orthopedics franchise (Journey knee, Polarstem hip, Anthology hip) competing directly with Corentec's joint reconstruction products. Comparable premium positioning and global distribution footprint.
• DePuy Synthes (Johnson & Johnson): DePuy Synthes, J&J's orthopedics unit, offers Attune knee and Corail hip systems that directly compete with Corentec's Exult knee and Bencox hip lines. As the largest orthopedic franchise globally, it sets the standard for surgeon relationships and hospital contracts.
• B. Braun (Aesculap): B. Braun's Aesculap division manufactures knee (Columbus), hip (Metha, Bicontact), and spine implants, directly competing with Corentec's joint reconstruction and spine portfolio. As a German medical device conglomerate, it represents a comparable mid-tier competitor with global distribution.
• DJO / Enovis: Enovis (formerly DJO) operates a significant orthopedic implants business including hip and knee products, competing with Corentec across multiple joint categories. Comparable product breadth in reconstruction plus additional surgical and recovery segments.

Emerging players

• ConforMIS: ConforMIS is a US-based orthopedic company specializing in patient-specific 3D-printed knee implants, making it a direct emerging competitor to Corentec's 3D-printed custom implant strategy. Comparable technology approach and focus on personalized joint reconstruction, though ConforMIS is private and Corentec has broader product portfolio.

Direct peers

• Exactech: Exactech is a US orthopedic implant company specializing in knee, hip, shoulder, and spine products, directly comparable to Corentec's five-category portfolio. Similar mid-size scale, similar product breadth, and similar competitive positioning against the top four global players.
• Waldemar Link: Waldemar Link is a German family-owned orthopedic implant company specializing in hip, knee, and revision systems, directly comparable to Corentec's specialty-focused portfolio. Similar mid-size, family/investor-owned structure with niche differentiation in joint reconstruction.

Regional players

• AK Medical Holdings: AK Medical is a Chinese orthopedic implant manufacturer specializing in hip and knee joints, comparable to Corentec as an Asia-based mid-tier joint reconstruction specialist. Both target regional market dominance before expanding globally, with similar product portfolios focused on cost-competitive joint implants.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights7 records

Customer concentration

Compliance5 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Subsidiaries1 record

Funding overview

Funding rounds2 records

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Corentec